CXCL13 and myeloid sarcoma: In another study, the number of relapses over a 5-year period in patients with an established diagnosis of MS was related to the CSF concentration of CXCL13.11 The authors did not provide data on treatment status of these patients, but presumably they were not left untreated for 5 years.